In vitro cultured calculus bovis alleviates cerebral ischemia/reperfusion injury through regulating microglial polarization and inhibiting NLRP3.
10.3724/zdxbyxb-2024-0573
- Author:
Tanlu CHU
1
;
Wei ZHANG
2
;
Jingwen CHEN
2
;
Zeyue PAN
2
;
Lingfeng WANG
3
;
Xiaoming ZHONG
2
;
Fengmei QIU
2
;
Zhen HUANG
4
Author Information
1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. 651958476@qq.com.
2. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
3. Jinhua Academy of Zhejiang Chinese Medical University, Jinhua 321053, Zhejiang Province, China.
4. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. huangzhen@zcmu.edu.cn.
- Publication Type:Journal Article
- Keywords:
Cerebral ischaemia-reperfusion injury;
In vitro cultured calculus bovis;
Inflammasome;
Microglia;
NOD-like receptor thermal protein domain associated protein 3;
SD rats
- MeSH:
Animals;
Rats, Sprague-Dawley;
Reperfusion Injury/prevention & control*;
Microglia/metabolism*;
Rats;
NLR Family, Pyrin Domain-Containing 3 Protein;
Brain Ischemia/metabolism*;
Male
- From:
Journal of Zhejiang University. Medical sciences
2025;54(3):360-371
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the effect of in vitro cultured calculus bovis (ICCB) on cerebral ischemia/reperfusion injury (CIRI) and its mechanism.
METHODS:A CIRI rat model and a cell model were induced by middle cerebral artery occlusion (MCAO) in Sprague Dawley rats and oxygen glucose deprivation/reperfusion (OGD/R) in BV2 cells, respectively. The CIRI rat model was evaluated using the modified neurological severity score (mNSS), brain water content, and cerebral infarction volume after 1.5 h of ischemia followed by 72 h of reperfusion. Histopathological changes in the cortex and hippocampal CA1 region were observed with hematoxylin and eosin staining. Microglial polarization and NOD-like receptor thermal protein domain associated protein (NLRP) 3 inflammasome expression in the cortex were examined by immunofluorescence. BV2 cell viability was measured via MTT assay after treatment with ICCB and Nigericin. The expressions of NLRP3, ASC, caspase-1 proteins and inflammatory cytokines were detected with Western blotting in OGD/R treated BV2 cells (0.5 h OGD+24 h reperfusion) and in cells pretreated with Nigericin for 24 h.
RESULTS:ICCB treatment significantly improved neurological function, reduced cerebral infarct volume and brain water content, and mitigated pathological damage in the cortical and hippocampal CA1 regions of rats subjected to CIRI (all P<0.05). ICCB promoted the transition of cortical microglia from M1 to M2 phenotypes and suppressed NLRP3 activation in microglial cells (all P<0.01). ICCB significantly down-regulated the expression of NLRP3, ASC, and caspase-1 proteins, and reduced the secretion of IL-18 and IL-1β in BV2 cells of OGD/R model (all P<0.01). In addition, Nigericin significantly reversed the salvage effect of ICCB on model cells (both P<0.01) and the modulation of inflammatory cytokines (P<0.05).
CONCLUSIONS:ICCB exerts a protective effect against CIRI by mitigating neuroinflammation, through the reduction of M1 microglial polarization, promotion of M2 conversion, and suppression of the NLRP3/ASC/caspase-1 signaling pathway.
